Atlas FDA

SURGIFLO® Hemostatic Matrix, SURGIFLO® Hemostatic Matrix Kit with Thrombin, SURGIFOAM® Absorbable Gelatin Sponge, U.S.P.

FDA premarket approval P990004/S070 · decided 2025-01-27

Approval details

PMA number
P990004
Supplement
S070
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
SURGIFLO® Hemostatic Matrix, SURGIFLO® Hemostatic Matrix Kit with Thrombin, SURGIFOAM® Absorbable Gelatin Sponge, U.S.P.
Generic name
Agent, absorbable hemostatic, collagen based
Applicant
Ferrosan Meidcal Devices A/S
Date received
2024-12-30
Decision date
2025-01-27
Days to decision
28 days
Decision code
OK30
Product code
LMF
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Soeborg
Statement
for the qualification of an expansion of the cleanroom capacity (Basis Expansion) at Ferrosan Medical Devices A/S (FeMD).

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.